Clinical trial
Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents
NCT04336605 is registered in ClinicalTrials.gov with Norwegian Center for Violence and Traumatic Stress Studies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents
- Lead sponsor
- Norwegian Center for Violence and Traumatic Stress Studies
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 1, 2020
- Completion date
- January 31, 2025
- Enrollment
- 25,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
addiction, prescription drug dependence, psychiatric illness, ptsd